December 2008 · Vol. 20, No. 12YOU HAVE A NEW JOB: Monitor the lipid profile
The standard panel provides more details than you might imagine about your patient’s risk of cardiovascular disease
|
Fast Track
The best lipid concentration estimate of apoB is the calculated non-HDL-C value
Both NCEP ATP-III and AHA Women’s Guidelines use the total cholesterol/HDL ratio as a powerful risk predictor
|
|
Thomas
Dayspring,
MD;
Alan
Helmbold,
DODr. Dayspring is Director of the North Jersey Institute of Menopausal Lipidology in Wayne, NJ, and a Diplomate of the American Board of Internal Medicine and American Board of Clinical Lipidology.
Dr. Helmbold is a Cardiology Fellow at Brooke Army Medical Center at Fort Sam Houston, Texas, and a Diplomate of the American Board of Internal Medicine and American Board of Clinical Lipidology.
Dr. Dayspring serves on the advisory board for LipoScience. Dr. Helmbold reports no financial relationships relevant to this article.
Add another item to your ever-growing list of responsibilities: monitoring your patients’ risk of atherosclerosis.
|
